優博訊(300531.SZ):公司加大在人工智能領域佈局,研發方向主要為機器視覺、生物識別、自動規劃、智能控制等方面的算法和應用
格隆匯5月27日丨優博訊(300531.SZ)在投資者互動平台表示,近年來,公司加大在人工智能領域佈局,研發方向主要為機器視覺、生物識別、自動規劃、智能控制等方面的算法和應用,相關軟硬件產品及解決方案已應用於智慧物流、智能製造、智慧醫療和智慧零售等行業場景。隨着AI大模型應用的普及,公司未來將根據不同行業用户的需求,結合不同業務和場景,為行業客户提供更多深度定製化、垂直化的企業AI數字化工具。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.